Promoting Osteoblastogenesis Using a Novel Dkk-1 Neutralizing Antibody in the Treatment of Multiple Myeloma Related Bone Disease.

被引:0
|
作者
Pozzi, Samantha [1 ]
Yan, Hua
Vallet, Sonia
Vaghela, Nileshwari
Fulciniti, Mariateresa
Cirstea, Diana
Santo, Loredana
Mukherjee, Siddhartha
Hideshima, Teru
Schirtzinger, Linda [2 ]
Kuhstoss, Stuart [2 ]
Munshi, Nikhil C.
Anderson, Kenneth C.
Scadden, David
Raje, Noopur [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med,Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Boston, MA USA
[2] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:946 / 946
页数:1
相关论文
共 50 条
  • [1] Preclinical Validation of a Novel Dkk-1 Neutralizing Antibody for the Treatment of Multiple Myeloma Related Bone Disease.
    Pozzi, S.
    Yan, H.
    Vallet, S.
    Vaghela, N.
    Cirstea, D.
    Santo, L.
    Mukheriee, S.
    Hideshima, T.
    Schirtzinger, L.
    Kuhstoss, S.
    Anderson, K. C.
    Scadden, D.
    Raje, N.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S300 - S300
  • [2] Serum concentrations of DKK-1 correlate with the extent of bone disease in multiple myeloma
    Kaiser, Martin
    Mieth, Maren
    Liebisch, Peter
    Rotzer, Susanne
    Peters, Malte
    Sezer, Orhan
    Heider, Ulrike
    Jakob, Christian
    Fleissner, Claudia
    Braendle, Edgar
    Stover, David
    BLOOD, 2007, 110 (11) : 1030A - 1030A
  • [3] Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma
    Kaiser, Martin
    Mieth, Maren
    Liebisch, Peter
    Oberlaender, Romy
    Rademacher, Jessica
    Jakob, Christian
    Kleeberg, Lorenz
    Fleissner, Claudia
    Braendle, Edgar
    Peters, Malte
    Stover, David
    Sezer, Orhan
    Heider, Ulrike
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2008, 80 (06) : 490 - 494
  • [4] Regulation of Sclerostin Expression in Multiple Myeloma by Dkk-1: A Potential Therapeutic Strategy for Myeloma Bone Disease
    Eda, Homare
    Santo, Loredana
    Wein, Marc N.
    Hu, Dorothy Z.
    Cirstea, Diana D.
    Nemani, Neeharika
    Tai, Yu-Tzu
    Raines, Sarah E.
    Kuhstoss, Stuart Allen
    Munshi, Nikhil C.
    Kronenberg, Henry M.
    Raje, Noopur S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2016, 31 (06) : 1225 - 1234
  • [5] Inhibiting Dickkopf-1 (Dkk-1) prevents the development of osteolytic bone disease in multiple myeloma
    Heath, D. J.
    Chantry, A. D.
    Buckle, C.
    Coulton, L.
    Shaughnessy, J. D., Jr.
    Evans, H.
    Stover, D. R.
    Vanderkerken, K.
    Croucher, P. I.
    CALCIFIED TISSUE INTERNATIONAL, 2008, 83 (01) : 6 - 6
  • [6] Inhibiting dickkopf-1 (Dkk-1) prevents the development of osteolytic bone disease in multiple myeloma
    Heath, Debby
    Chantry, Andrew
    Buckle, Clive
    Coulton, Les
    Shaughnessy, John, Jr.
    Evans, Holly
    Stover, David
    Vanderkerken, Karin
    Croucher, Peter
    CANCER TREATMENT REVIEWS, 2008, 34 : S52 - S52
  • [7] In vivo and in vitro effects of a novel anti-Dkk1 neutralizing antibody in multiple myeloma
    Pozzi, Samantha
    Fulciniti, Mariateresa
    Yan, Hua
    Vallet, Sonia
    Eda, Homare
    Patel, Kishan
    Santo, Loredana
    Cirstea, Diana
    Hideshima, Teru
    Schirtzinge, Linda
    Kuhstoss, Stuart
    Anderson, Kenneth C.
    Munshi, Nikhil
    Scadden, David
    Kronenberg, Henry M.
    Raje, Noopur
    BONE, 2013, 53 (02) : 487 - 496
  • [8] Serum concentrations of DKK-1 decrease in patients with multiple myeloma responding to anti-myeloma treatment
    Heider, Ulrike
    Kaiser, Martin
    Mieth, Maren
    Lamottke, Britta
    Rademacher, Jessica
    Jakob, Christian
    Braendle, Edgar
    Stover, David
    Sezer, Orhan
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 82 (01) : 31 - 38
  • [9] Dkk1 modulates osteoclastogenesis and bone resorption: Implications for myeloma bone disease.
    Oyajobi, BO
    Gupta, A
    Flores, A
    Wideman, C
    Shipman, C
    Mundy, GR
    Garrett, IR
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S32 - S32
  • [10] Bone Marrow DKK-1 Levels Identify Patients With Smoldering Myeloma With Higher Risk of Progression to Active Multiple Myeloma
    Giuliani, Nicola
    Palma, Benedetta Dalla
    Marchica, Valentina
    Accardi, Fabrizio
    Notarfranchi, Laura
    Costa, Federica
    De Luca, Federica
    Guasco, Daniela
    Pedrazzoni, Mario
    Aversa, Franco
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E35 - E35